Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Agrigento, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on Immunoglobulin A Nephropathy (IgAN), a kidney condition affecting the filtration system. These studies aim to evaluate new therapeutic approaches for preserving kidney function in adult patients.
Research explores the potential of novel treatments to improve outcomes for patients with chronic kidney conditions, specifically targeting protein excretion and glomerular filtration rates.
Investigation into immune system-mediated kidney disorders, examining innovative therapeutic interventions that could modify disease progression and improve patient outcomes.
The research focuses on understanding and treating autoimmune kidney conditions through targeted therapeutic approaches.
Clinical evaluation of novel therapeutic compounds designed to address specific pathways involved in kidney disease, with a focus on comparing new treatments against established standards.
Studies aim to validate new treatment options that could potentially transform the management of chronic kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
